204 related articles for article (PubMed ID: 16860046)
21. Effect of "missed" pills on oral contraceptive effectiveness.
Letterie GS; Chow GE
Obstet Gynecol; 1992 Jun; 79(6):979-82. PubMed ID: 1579326
[TBL] [Abstract][Full Text] [Related]
22. Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills.
Arbo E; Vetori DV; Jimenez MF; Freitas FM; Lemos N; Cunha-Filho JS
Hum Reprod; 2007 Dec; 22(12):3192-6. PubMed ID: 17981819
[TBL] [Abstract][Full Text] [Related]
23. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval.
Sulak P; Willis S; Kuehl T; Coffee A; Clark J
Headache; 2007 Jan; 47(1):27-37. PubMed ID: 17355491
[TBL] [Abstract][Full Text] [Related]
24. Regulation of circulating gonadotropins by the negative effects of ovarian hormones in mares.
Ginther OJ; Gastal EL; Gastal MO; Beg MA
Biol Reprod; 2005 Aug; 73(2):315-23. PubMed ID: 15829621
[TBL] [Abstract][Full Text] [Related]
25. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L
Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
[TBL] [Abstract][Full Text] [Related]
26. Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone.
Jayaprakasan K; Campbell BK; Hopkisson JF; Clewes JS; Johnson IR; Raine-Fenning NJ
Hum Reprod; 2008 Nov; 23(11):2577-83. PubMed ID: 18658161
[TBL] [Abstract][Full Text] [Related]
27. Ovarian function and regulation of the hypothalamic-pituitary-ovarian axis after tubal sterilization.
Timonen S; Tuominen J; Irjala K; Mäenpää J
J Reprod Med; 2002 Feb; 47(2):131-6. PubMed ID: 11883352
[TBL] [Abstract][Full Text] [Related]
28. Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases.
van den Berg MH; van Dulmen-den Broeder E; Overbeek A; Twisk JW; Schats R; van Leeuwen FE; Kaspers GJ; Lambalk CB
Hum Reprod; 2010 Jun; 25(6):1520-7. PubMed ID: 20348556
[TBL] [Abstract][Full Text] [Related]
29. [Central and peripheral actions of an oral contraceptive with reduced oestrogen content (author's transl)].
Schneider WH; Schmid R; Spona J
Wien Klin Wochenschr; 1977 Apr; 89(9):311-3. PubMed ID: 855349
[TBL] [Abstract][Full Text] [Related]
30. Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women.
Wunder DM; Bersinger NA; Yared M; Kretschmer R; Birkhäuser MH
Fertil Steril; 2008 Apr; 89(4):927-33. PubMed ID: 17603052
[TBL] [Abstract][Full Text] [Related]
31. Developmental changes of plasma inhibin, gonadotropins, steroid hormones, and thyroid hormones in male and female Shao ducks.
Yang P; Medan MS; Watanabe G; Taya K
Gen Comp Endocrinol; 2005 Sep; 143(2):161-7. PubMed ID: 16061074
[TBL] [Abstract][Full Text] [Related]
32. [Hormone determination in the management and monitoring of cycles of medically-assisted reproductive technology: value and difficulties of use].
Taieb J; Benattar C; Poüs C
Ann Biol Clin (Paris); 2003; 61(5):533-40. PubMed ID: 14671750
[TBL] [Abstract][Full Text] [Related]
33. Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women.
Santoro N; Lo Y; Moskaleva G; Arnsten JH; Floris-Moore M; Howard AA; Adel G; Zeitlian G; Schoenbaum EE
Menopause; 2007; 14(5):859-65. PubMed ID: 17415019
[TBL] [Abstract][Full Text] [Related]
34. [Ovarian suppressive activity of a low dose monophasic oral contraceptive during correct and incorrect pill intake].
Vallon AM; Cristol P; Hedon B; Deschamps F; Plauchut A; Taillant M; Pizelle AM
Contracept Fertil Sex (Paris); 1992 May; 20(5):521-9. PubMed ID: 12343759
[TBL] [Abstract][Full Text] [Related]
35. Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen.
Sulak PJ; Kuehl TJ; Coffee A; Willis S
Am J Obstet Gynecol; 2006 Oct; 195(4):935-41. PubMed ID: 16647684
[TBL] [Abstract][Full Text] [Related]
36. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
[TBL] [Abstract][Full Text] [Related]
37. Studies of pituitary gonadotropin response to graded GNRF injections in women using a low-estrogen oral contraceptive for six months.
Spellacy WN; Kalra PS; Birk SA; Buggie J
Infertility; 1980; 3(2):97-105. PubMed ID: 12310950
[TBL] [Abstract][Full Text] [Related]
38. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen.
Coffee AL; Sulak PJ; Kuehl TJ
Contraception; 2007 Jun; 75(6):444-9. PubMed ID: 17519150
[TBL] [Abstract][Full Text] [Related]
39. A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles.
Robertson DM; Hale GE; Fraser IS; Hughes CL; Burger HG
Menopause; 2008; 15(6):1139-44. PubMed ID: 18779761
[TBL] [Abstract][Full Text] [Related]
40. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
